SpotSense

SpotSense is an in-vitro diagnostics startup based in Bangalore, India, founded in 2016. The company specializes in bedside rapid near-patient diagnostics and saliva-based point-of-care testing. SpotSense develops high-accuracy, non-invasive diagnostic tools that enable healthcare providers and home users to perform quick and reliable tests anytime and anywhere. Their flagship product, Droolie, is the world's first non-invasive diagnostic tool for newborn sepsis screening, utilizing a small salivary sample to detect biomarkers indicating systemic inflammatory response. SpotSense also offers a range of diagnostic tests for infectious diseases, respiratory and metabolic disorders, anemia, and other non-communicable diseases. Their product VIEWDx integrates multiple test formats into a single device, enhancing versatility for clinicians. SpotSense emphasizes ease of use, accuracy, and accessibility in its technology. Their medical devices feature user-friendly interfaces and advanced diagnostics, suitable for both healthcare professionals and home users. The company aims to empower patients with bloodless, saliva-based testing for monitoring disease progression and treatment effectiveness.

• Employees 11
• Founded 2016